Scancell Holdings plc
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 for the treatment of non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a prophylactic DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom. Show More...
-
Website https://www.scancell.co.uk
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.08 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-04 2011-04 2012-04 2013-04 2014-04 2015-04 2016-04 2017-04 2018-04 2019-04 TTM Earnings Per Share GBP -0.02 -0.1 -0.010 -0.010 -0.010 -0.010 -0.010 -0.010 -0.010 -0.010 Dividends GBP Payout Ratio % * Shares Mil 107.0 18.0 205.0 194.0 217.0 225.0 228.0 262.0 313.0 387.0 419.0 Book Value Per Share * EUR 0.05 0.05 0.03 0.04 0.03 0.04 0.03 Free Cash Flow Per Share * EUR -0.010 -0.010 -0.010 -0.02 -0.02 -0.02 Return on Assets % -29.14 -29.29 9.27 -30.04 -29.6 -28.45 -28.82 -40.29 -38.72 -44.7 -41.07 Financial Leverage (Average) 1.07 1.03 1.04 1.06 1.06 1.09 1.06 1.08 1.05 1.13 1.07 Return on Equity % -30.74 -30.87 9.6 -31.53 -31.38 -30.5 -30.85 -42.99 -41.04 -48.35 -43.32 Return on Invested Capital % -30.77 -31.05 9.06 -31.97 -31.75 -31.92 -30.99 -43.5 -41.06 -48.46 -43.43 Interest Coverage Current Ratio 6.53 10.2 13.13 5.9 11.32 6.39 12.31 6.62 16.01 5.86 10.23 Quick Ratio 6.5 9.81 12.41 4.73 10.35 5.07 11.34 5.02 14.8 3.78 8.1 Debt/Equity